Clinical Data UCB reports positive outcomes for bimekizumab in psoriatic arthritis PharmaTimesTrial shows first headtohead superiority in joint endpoints for an approved PsA biologicImmunology & InflammationRead full story pharminent May 19, 2026 (Last updated: May 19, 2026) PharmaTimes Trial shows first headtohead superiority in joint endpoints for an approved PsA biologic Immunology & Inflammation Read full story Post navigation Previous: European study shows inequality in access to new medicinesNext: BioMarin suffers another blow to rare disease portfolio in Phase 3 flop Related Stories Clinical Data Novo Nordisk starts trialing lower maintenance doses of oral Wegovy pharminent August 21, 2026 Clinical Data Cancer vaccine win restores Wall Street’s faith in Moderna pharminent August 20, 2026 Clinical Data New Taiho, Cullian data heats up lung cancer drug battle pharminent August 13, 2026
